Christine Crish

Has grant

Associate Professor (tenured)

Northeast Ohio Medical University
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

Christine Crish is an Assistant Professor at Northeast Ohio Medical University in the United States. Her research primarily focuses on topics related to neurobiology, bone remodeling, and histomorphogenesis, as evidenced by her recent publications. Notable articles include investigations into irisin treatment effects on tau levels in pre-symptomatic mice and bone remodeling in the naked mole-rat, highlighting her expertise in comparative biology and metabolic processes.

Recent Grants

Grant: Close

Fingolimod as a neuroprotectant against visual system pathology in Alzheimer's disease

Open Date: 2019-07-01

Close Date: 2019-09-01

Grant: Close

Visual system dysfunction in Alzheimer's disease

Open Date: 2018-01-01

Close Date: 2019-01-01

Grant: Close

Disruption of sensory pathways in dementia pathogenesis

Open Date:

Close Date:

Grant: Close

Linking integrin dysfunction with tauopathy in a LOAD model

Open Date:

Close Date:

Articles (6)

There is growing interest in understanding the mechanisms underlying differences in cancer incidence among species (comparative oncology). The naked mole rat (NMR) is often referenced as “cancer resistant” and prior studies focused on identifying mechanisms explaining this. However, efforts to assess this in vivo have been limited. In this study, we provide evidence that the NMR presents as a novel autochthonous model of lung tumor initiation, driven by an introduction of the oncogenic Eml4-Alk fusion gene using CRISPR-mediated genome editing. Although in mice, the inversion alone is sufficient to drive tumorigenesis, the inversion alone was insufficient to drive tumorigenesis in the NMR lung, and tumor development required additional losses of the tumor suppressors p53 and pRb. Our findings suggest that the proposed “resistance” of the NMR to the development of cancer may reflect that the genetic events leading to tumor initiation are likely to be comparable with those present in human cells. Significance: To identify evolutionary divergent mechanisms of cancer resistance, we assessed tumorigenesis in vivo using the NMR, a species considered to exhibit cancer resistance. Our findings suggest that the proposed “resistance” of NMRs to the development of cancer may reflect tumor initiation mechanisms comparable with the mechanisms present in humans. See related commentary by Boddy and Abegglen, p. 7

Year:

2026

Year:

2025

Year:

2025

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Walid Khaled

University lecturer

University of Cambridge

UNITED KINGDOM
View details

Thomas Park

Professor

University of Chicago

UNITED STATES
View details

Andrea Ventura

Member

Memorial Sloan Kettering Cancer Center

UNITED STATES
View details

Woo Shik Shin

Northeast Ohio Medical University

UNITED STATES
View details

Ewan Smith

Head of Department

University of Cambridge

UNITED KINGDOM
View details

Elsa Flores

Associate Center Director, Basic Science

H Lee Moffitt Cancer Center and Research Institute

UNITED STATES
View details

Kenneth Tsai

Vice Chair of Research, Senior Member

H Lee Moffitt Cancer Center and Research Institute

UNITED STATES
View details